Literature DB >> 19255046

Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy.

Kimberly A Yonkers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19255046      PMCID： PMC3094692          DOI： 10.1176/appi.ajp.2008.08111703

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  10 in total

1.  Antenatal depression: navigating the treatment dilemmas.

Authors:  Marlene P Freeman
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

2.  Teratogenicity of SSRIs--serious concern or much ado about little?

Authors:  Michael F Greene
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

3.  Selective serotonin reuptake inhibitor use and risk of gestational hypertension.

Authors:  Sengwee Toh; Allen A Mitchell; Carol Louik; Martha M Werler; Christina D Chambers; Sonia Hernández-Díaz
Journal:  Am J Psychiatry       Date:  2009-01-02       Impact factor: 18.112

4.  Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.

Authors:  Tim F Oberlander; William Warburton; Shaila Misri; Jaafar Aghajanian; Clyde Hertzman
Journal:  Br J Psychiatry       Date:  2008-05       Impact factor: 9.319

5.  The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida.

Authors:  I J Chasnoff; H J Landress; M E Barrett
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

6.  Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

Authors:  Bengt A J Källén; Petra Otterblad Olausson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-04

Review 7.  Pre-eclampsia.

Authors:  Baha Sibai; Gus Dekker; Michael Kupferminc
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

8.  Outcomes of prenatal antidepressant exposure.

Authors:  Gregory E Simon; Michael L Cunningham; Robert L Davis
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

9.  Depression and anxiety in early pregnancy and risk for preeclampsia.

Authors:  T Kurki; V Hiilesmaa; R Raitasalo; H Mattila; O Ylikorkala
Journal:  Obstet Gynecol       Date:  2000-04       Impact factor: 7.661

10.  Can SSRIs reduce the risk of preeclampsia in pregnant, depressed patients?

Authors:  Shandara Durkee Dawes
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538
  10 in total
  2 in total

1.  Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia.

Authors:  Julie A Vignato; S Banu Gumusoglu; Heather A Davis; Sabrina M Scroggins; Wendy S Hamilton; Debra S Brandt; Gary L Pierce; Boyd A Knosp; Donna A Santillan; Mark K Santillan
Journal:  Reprod Sci       Date:  2022-08-19       Impact factor: 2.924

2.  A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.

Authors:  Tim F Oberlander; Katherine L Wisner
Journal:  Can J Psychiatry       Date:  2012-09       Impact factor: 4.356
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.